Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-030930
Filing Date
2021-02-05
Accepted
2021-02-05 17:15:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d128896d424b5.htm 424B5 422189
2 GRAPHIC g128896g53k90.jpg GRAPHIC 59460
3 GRAPHIC g128896g63o92.jpg GRAPHIC 46778
  Complete submission text file 0001193125-21-030930.txt   569771
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-231010 | Film No.: 21597217
SIC: 2834 Pharmaceutical Preparations